HALO logo
halo search icon
ARS Pharmaceuticals, Inc.

US$7.80

Price Change Indicator
0.63 (8.79%)
ARS Pharmaceuticals, Inc.
SPRY · NAS

ARS Pharmaceuticals, Inc.

Start Trading SPRY for Free

US$7.80

Price Arrow0.63 (8.79%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueRecent Earnings downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

ARS Pharmaceuticals, Inc. Overview

SPRY Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About SPRY

icon
icon

Telephone

1.858.771.9307

icon

Address

Suite 300, 11682 El Camino Real, San Diego, CA 92130

Description

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

SPRY Price Chart

Key Stats

Market Cap

US$712.00M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 6.66 - 18.9

Trade Value (12mth)

US$5,088,293.00

1 week

-3.43%

1 month

-8.55%

YTD

-37.6%

1 year

-49.58%

All time high

63.41

Key Fundamentals

EPS 3 yr Growth

100.20%

EBITDA Margin

-211.30%

Operating Cashflow

-$171m

Free Cash Flow Return

-73.10%

ROIC

-73.30%

Interest Coverage

-68.50

Quick Ratio

7.10

Other Data

Shares Outstanding (Fully Diluted)

99m

HALO Sector

Healthcare

Next Company Report Date

25-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

SPRY Announcements

Latest Announcements

DateAnnouncements
15 May 26
15 May 26
15 May 26
15 May 26
13 May 26

SPRY Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.570.08-1.74locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.570.08-1.74locklocklock
Growth
 %locklocklocklock34.2114.4-2,206.5locklocklock
PE
 XlocklocklocklockN/A135.1N/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of ARS Pharmaceuticals, Inc. (SPRY:NAS)?
Halo FAQ
The current share price of ARS Pharmaceuticals, Inc. (SPRY:NAS) is USD$7.80.
What is the 52-week high share price for ARS Pharmaceuticals, Inc. (SPRY:NAS)?
Halo FAQ
The 52-week high share price for ARS Pharmaceuticals, Inc. (SPRY:NAS) is USD$18.90.
What is the 52-week low share price for ARS Pharmaceuticals, Inc. (SPRY:NAS)?
Halo FAQ
The 52-week low share price for ARS Pharmaceuticals, Inc. (SPRY:NAS) is USD$6.66.
What is the dividend yield for ARS Pharmaceuticals, Inc. (SPRY:NAS)?
Halo FAQ
ARS Pharmaceuticals, Inc. (SPRY:NAS) does not pay a dividend.
What was ARS Pharmaceuticals, Inc. (SPRY:NAS) last dividend payment?
Halo FAQ
ARS Pharmaceuticals, Inc. (SPRY:NAS) does not pay a dividend.
What is the franking level for ARS Pharmaceuticals, Inc. (SPRY:NAS)?
Halo FAQ
ARS Pharmaceuticals, Inc. (SPRY:NAS) has a franking level of 0.00%.
In which sector is ARS Pharmaceuticals, Inc. (SPRY:NAS) classified?
Halo FAQ
ARS Pharmaceuticals, Inc. (SPRY:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial